Skip to content

Acupuncture treatment with ultrasound for neurological tinnitus: a randomized controlled trial

Acupuncture treatment with ultrasound for neurological tinnitus: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084381
Enrollment
Unknown
Registered
2024-05-15
Start date
2024-06-01
Completion date
Unknown
Last updated
2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurological tinnitus

Interventions

Sham acupuncture group:Ultrasound-guided needling of acupuncture points in the superficial fascial layer
Acupuncture group :Ultrasound-guided needling of acupuncture points in the deep fascial layer

Sponsors

Tongde Hospital of Zhejiang Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: ? Meet the diagnostic criteria for tinnitus nervosa. ? Age 18-65 years old. ?Patients with unilateral tinnitus. ?The severity of tinnitus is grade II to IV. ?Those who have persistent attacks for more than 5d or recurring attacks for less than 1-6 months. ?Can cooperate in completing various tinnitus examinations and carefully complete the subjective tinnitus survey information sheet. ? Participate voluntarily and sign the informed consent form.

Exclusion criteria

Exclusion criteria: ?Patients with bilateral tinnitus. ?Pregnant or lactating women. ? Tinnitus caused by tumour or systemic diseases (e.g. tympanic space-occupying lesion, acoustic neuroma, brain tumour, hyperthyroidism, renal disease). ?Total deafness with tinnitus, combined with cardiovascular and cerebrovascular diseases and liver, kidney, haematopoietic system and other serious primary diseases and psychiatric patients. ?Those with organic damage caused by trauma or infection (such as cerumen impaction, foreign body in external ear canal, otitis media). ?Those who has other serious complications, such as heart disease, high blood pressure, cerebral infarction, etc. ? Those who use other drugs or therapeutic measures related to the treatment of this disease 1 week before or during the treatment that may affect the determination of the efficacy.

Design outcomes

Primary

MeasureTime frame
Tinnitus Handicap Inventory;

Secondary

MeasureTime frame
Tinnitus Severity Assessment Scale;Self-rating Anxiety Scale;

Countries

China

Contacts

Public ContactHao Liu; Xiaoqing Yu

Tongde Hospital of Zhejiang Province; The Second Clinical College of Zhejiang University of Traditional Chinese Medicine

Haoliu1987@aliyun.com+86 158 6881 4927

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026